Showing results (331-340 of 374) with videos related to

Sort By:
Pageof 38
Lung Cancer (Amsterdam, Netherlands)|June 12, 2002
A phase II study testing paclitaxel as second-line single agent treatment for patients with advanced non-small cell lung cancer failing after a first-line chemotherapyJ P Sculier, T Berghmans, J J Lafitte, et al.
European Journal of Clinical Investigation|September 22, 2007
Markers of inflammation and disuse in vastus lateralis of chronic obstructive pulmonary disease patientsT Crul, M A Spruit, G Gayan-Ramirez, et al.
European Journal of Applied Physiology|September 14, 2000
Different effects of corticosteroid-induced muscle wasting compared with undernutrition on rat diaphragm energy metabolismE Koerts-de Lang, A M Schols, O E Rooyackers, et al.
Thorax|August 30, 2003
Muscle force during an acute exacerbation in hospitalised patients with COPD and its relationship with CXCL8 and IGF-IM A Spruit, R Gosselink, T Troosters, et al.
The European Respiratory Journal|August 22, 2008
Skeletal muscle weakness, exercise tolerance and physical activity in adults with cystic fibrosisT Troosters, D Langer, B Vrijsen, et al.
The European Respiratory Journal|November 5, 2002
Impact of COPD in North America and Europe in 2000: subjects' perspective of Confronting COPD International SurveyS Rennard, M Decramer, P M A Calverley, et al.
Critical Care Medicine|February 7, 2001
Incentive spirometry does not enhance recovery after thoracic surgeryR Gosselink, K Schrever, P Cops, et al.
The European Respiratory Journal|May 31, 2011
The TERT-CLPTM1L locus for lung cancer predisposes to bronchial obstruction and emphysemaE Wauters, D Smeets, J Coolen, et al.
Journal of Applied Physiology: Respiratory, Environmental and Exercise Physiology|August 1, 1981
Model of elasticity of the human lungR De Wilde, J Clément, J M Hellemans, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 28, 2002
A phase II randomised trial comparing the cisplatin-etoposide combination chemotherapy with or without carboplatin as second-line therapy for small-cell lung cancerJ P Sculier, J J Lafitte, J Lecomte, et al.
Pageof 38